🇺🇸 FDA

Company profile · Sponsor

ACTUATE

ACTUATE THERAPEUTICS, INC.

ACTU · NYSE pharma FORT WORTH, TX, USA
Pipeline
12
Drugs
0
Patents
7

Quick answer

ACTUATE (ACTU) is a pharma company. headquartered in FORT WORTH, TX, USA. listed on NYSE. NovaPharmaNews links 12 pipeline programs, 0 drugs, and 7 patents to this profile..

Company facts

Ticker ACTU
Exchange NYSE
Company type pharma
Headquarters FORT WORTH, TX, USA
SEC CIK 0001652935

Pipeline (12)

Search pipeline →

  1. 9-ING-41

    ACTUATE

    Salivary Gland Cancer

    phase 2 small molecule active

    1 trial

  2. 9-ING-41

    ACTUATE

    Cancer

    phase 2 small molecule active

    1 trial

  3. 9-ING-41

    ACTUATE

    Pancreatic Adenocarcinoma

    phase 2 small molecule terminated

    1 trial

  4. 9-ING-41

    ACTUATE

    Salivary Gland Carcinoma

    phase 2 small molecule terminated

    1 trial

  5. FOLFIRNINOX

    ACTUATE

    Pancreatic Adenocarcinoma

    phase 2 small molecule active

    1 trial

  6. Gemcitabine

    ACTUATE

    Soft Tissue Sarcoma

    phase 2 small molecule terminated

    1 trial

  7. Gemcitabine

    ACTUATE

    Sarcoma

    phase 2 small molecule terminated

    1 trial

  8. Gemcitabine 100 mg/ml Concentrate for Solution for Infusion, 9-ING-41, Abraxane 5 mg/ml powder for dispersion for infusion.

    ACTUATE

    Refractory Hematologic Malignancies or Solid Tumors

    phase 2 small molecule active

    1 trial

  9. Ruxolitinib

    ACTUATE

    Myelofibrosis

    phase 2 small molecule completed

    1 trial

  10. 9-ING-41

    ACTUATE

    Refractory Cancer

    phase 1 small molecule terminated

    1 trial

  11. Retifanlimab

    ACTUATE

    Pancreatic Adenocarcinoma

    phase 1 small molecule active

    1 trial

  12. Megestrol acetate

    ACTUATE

    HIV Infections

    small molecule completed

    1 trial

Patents (7)

Search patents →

  1. US 12145943

    Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12116374

    Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12083098

    Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form β inhibitors

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11980607

    Methods of treating malignant lymphoproliferative disorders

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11510904

    Methods of treating malignant lymphoproliferative disorders

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11407759

    Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11136334

    Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is ACTUATE?

ACTUATE (ACTU) is a pharma company. headquartered in FORT WORTH, TX, USA. listed on NYSE. NovaPharmaNews links 12 pipeline programs, 0 drugs, and 7 patents to this profile..

What pipeline programs does ACTUATE sponsor?

We track 12 ClinicalTrials.gov-linked programs for ACTUATE, including 9-ING-41 and 11 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does ACTUATE company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.